Recent Advances in the Care of Patients with Chronic Lymphocytic Leukemia (CLL)

Pharmacy Times Health Systems Edition, May 2018, Volume 7, Issue 3

This activity is supported by educational grants from Pharmacyclics LLC. An Abvie Company; Jannsen Biotech, Inc; and Cure Media Group

FACULTY

Jolynn K. Sessions, PharmD, BCOP

Associate Professor of Clinical Education

UNC Eshelman School of Pharmacy Oncology Clinical Pharmacist

SECU Mission Cancer Center Asheville, North Carolina

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

  • Explain the recommendations of the place in therapy for new and emerging CLL treatment options
  • Illustrate the management of relapsed and refractory CLL
  • Examine the management of adverse events and complications of novel therapies
  • Demonstrate how to implement strategies that improve communication, patient engagement, education, and decision making with patients with CLL and their health care providers

TARGET AUDIENCE: Clinical and specialty pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: April 25, 2018

EXPIRATION DATE: May 25, 2019

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.